Mawson Infrastructure Group Inc. — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2020-08-11

Reporting Person: Keret Yosef (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-11	Restricted Stock Units (RSU)	$	A	100000	Acquired		Common Stock (100000)	Direct

Footnotes

F1: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.

F2: Vest quarterly over a two year period commencing on the date of the grant.